Steven T. Miller

637 total citations
16 papers, 523 citations indexed

About

Steven T. Miller is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Immunology and Allergy. According to data from OpenAlex, Steven T. Miller has authored 16 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Immunology and Allergy. Recurrent topics in Steven T. Miller's work include Mast cells and histamine (8 papers), Ocular Surface and Contact Lens (7 papers) and Allergic Rhinitis and Sensitization (5 papers). Steven T. Miller is often cited by papers focused on Mast cells and histamine (8 papers), Ocular Surface and Contact Lens (7 papers) and Allergic Rhinitis and Sensitization (5 papers). Steven T. Miller collaborates with scholars based in United States, China and United Kingdom. Steven T. Miller's co-authors include John M. Yanni, Daniel A. Gamache, Joan M. Spellman, Najam A. Sharif, Lori K. Weimer, Shouxi Xu, G. Graff, David Farnell, Milton T. Brady and Gustav Graff and has published in prestigious journals such as Journal of Medicinal Chemistry, Clinical Orthopaedics and Related Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Steven T. Miller

14 papers receiving 511 citations

Peers

Countries citing papers authored by Steven T. Miller

Since Specialization

Citations

This map shows the geographic impact of Steven T. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven T. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven T. Miller more than expected).

Fields of papers citing papers by Steven T. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven T. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven T. Miller. The network helps show where Steven T. Miller may publish in the future.

Co-authorship network of co-authors of Steven T. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Steven T. Miller. A scholar is included among the top collaborators of Steven T. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven T. Miller. Steven T. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Understanding, inhibiting, and engineering membrane transporters with high-throughput mutational screens 2025 ·Cell chemical biology ·Steven T. Miller, Christian B. Macdonald, (unknown)	0
2	Google’s Advertising and Capital 2025 ·Science & Society ·Steven T. Miller	0
3	Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility 2023 ·Journal of Medicinal Chemistry ·(unknown), Steven T. Miller, (unknown), (unknown), (unknown), (unknown), Robert V. Brown, (unknown), (unknown), (unknown), Stuart Williams, Mitchell A. deLong, Jeffrey C. White, Casey Kopczynski, David A. Ellis	4
4	Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2–dependent activation of type II protein kinase A 2006 ·Molecular Cancer Therapeutics ·Troy D. Payner, H.A. Leaver, Brian I. Knapp, Ian R. Whittle, Ovidiu C. Trifan, Steven T. Miller, Maria Teresa Rizzo	35
5	Interactions of olopatadine and selected antihistamines with model and natural membranes 2003 ·Ocular Immunology and Inflammation ·Howard L. Brockman, Maureen M. Momsen, (unknown), Steven T. Miller, Gustav Graff, John M. Yanni	52
6	Corneal Protection by the Ocular Mucin Secretagogue 15(S)-HETE in a Rabbit Model of Desiccation-induced Corneal Defect 2002 ·Journal of Ocular Pharmacology and Therapeutics ·Daniel A. Gamache, (unknown), Lori K. Weimer, Steven T. Miller, Joan M. Spellman, John M. Yanni	26
7	A Current Appreciation of Sites for Pharmacological Intervention in Allergic Conjunctivitis: Effects of New Topical Ocular Drugs 1999 ·Acta Ophthalmologica Scandinavica ·John M. Yanni, Najam A. Sharif, Daniel A. Gamache, Steven T. Miller, Lori K. Weimer, Joan M. Spellman	35
8	Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells. 1998 ·PubMed ·(unknown), (unknown), Steven T. Miller, James E. Gern, (unknown), (unknown), (unknown)	41
9	Secretory Response of Mast Cells Contained in Monodispersed Human Choroidal Preparations 1997 ·International Archives of Allergy and Immunology ·Steven T. Miller, (unknown), Daniel A. Gamache, Joan M. Spellman, John M. Yanni	8
10	Comparative Effects of Topical Ocular Anti-Allergy Drugs on Human Conjunctival Mast Cells 1997 ·Annals of Allergy Asthma & Immunology ·John M. Yanni, Steven T. Miller, Daniel A. Gamache, Joan M. Spellman, Shouxi Xu, Najam A. Sharif	83
11	The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent 1996 ·Journal of Ocular Pharmacology and Therapeutics ·John M. Yanni, (unknown), Steven T. Miller, Lori K. Weimer, G. Graff, David Farnell, (unknown), Joan M. Spellman, Milton T. Brady, Daniel A. Gamache	96
12	Human conjunctival mast cell responses in vitro to various secretagogues 1996 ·Ocular Immunology and Inflammation ·Steven T. Miller, Ellen B. Cook, Frank M. Graziano, Joan M. Spellman, John M. Yanni	27
13	Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Najam A. Sharif, (unknown), Steven T. Miller, Daniel A. Gamache, John M. Yanni	99
14	26 Solubility Behavior of the Mineral Substance of Bone, Tooth and Shell 1970 ·Clinical Orthopaedics and Related Research ·R. M. Biltz, Edmund D. Pellegrino, Steven T. Miller, (unknown)	11
15	The solubility of several skeletal carbonates: I. Role of the carbonate ion. 1968 ·PubMed ·(unknown), R. M. Biltz, Steven T. Miller	2
16	Apparatus for Studying Ball Spinning Friction 1965 ·Defense Technical Information Center (DTIC) ·Steven T. Miller, R. J. Parker, Erwin V. Zaretsky	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact